Synergistic effect of immunoregulatory cytokines on peripheral blood onocytes from patients with inflammatory bowel disease

Digestive Diseases and Sciences

Volumn 42, Issue 4, 1997, Pages 805-812

  Kucharzik, Torsten ^a   Lügering, Norbert ^a   Adolf, Michael ^a   Domschke, Wolfram ^a   Stoll, Reinhard ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

inflammatory bowel disease; interleukin 10; interleukin 13; interleukin 4; monocytes

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MONOCYTE; PRIORITY JOURNAL;

EID: 0030949773     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018872332387     Document Type: Article

References (40)

1. Mazlam MZ, Hodgson HJF: Peripheral blood monocyte production and acute phase response in inflammatory bowel disease. Gut 33:773-778, 1992
2. 2+-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease. Digestion 56:406-414, 1995
3. Lügering N, Stoll R, Schmid KW, Kucharzik T, Stein H, Burmeister G, Sorg C, Domschke W: The myeloic related protein MRP8/14 (27E10 antigen) usefulness as a potential marker for disease activity in ulcerative colitis and putative biological function. Eur J Clin Invest 25:659-664, 1995
4. Mahida YR, Wu K, Jewell DP: Enhanced production of interleukin 1-β by mononuclear cells isolated from mucosa with active ulcerative colitis or Crohn's disease. Gut 28:745-753, 1987
5. Reinecker HC, Steffen M, Witthoeft T, Pfleuger I, Schreiber S, McDermott RP, Raedler A: Enhanced secretion of tumor necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 94:174-181, 1993
6. Hyams JS, Fitzgerald JE, Treem WR, Wyzga N, Kreutzer D: Relationship of functional and antigenic interleukin-6 to disease activity in inflammatory bowel disease. Gastroenterology 104:1285-1292, 1993
7. Mazlam MZ, Hodgson HJF: Interrelations between interleukin-6, interleukin-1β, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease. Gut 35:77-83, 1994
8. Murch SH, Braegger CP, Walker-Smith JA, MacDonald TT: Location of tumor necrosis factor a by immunohistochemistry in chronic inflammatory bowel disease. Gut 34:1705-1709, 1993
9. Isaacs KL, Sartor RB, Haskill JS: Cytokine mRNA profiles in inflammatory bowel disease mucosa detected by PCR amplification. Gastroenterology 103:1587-1595, 1992
10. Nakamura M, Saito H, Kasanuki J, Tamura Y, Yoshida S: Cytokine production in patients with inflammatory bowel disease. Gut 33:933-937, 1992
11. Kucharzik T, Stoll R, Lügering N, Domschke W: Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease. Clin Exp Immunol 100:452-456, 1995
12. Schreiber S, Heinig T, Panzer U, Reinking R, Bouchard A, Stahl PD, Raedler A: Impaired response of activated mononuclear phagocytes to interleukin-4 in inflammatory bowel disease. Gastroenterology 108:21-33, 1995
13. Schreiber S, Heinig T, Thiele H-G, Raedler A: Immunoregulatory role of interleukin-10 in patients with inflammatory bowel disease. Gastroenterology 108:1434-1444, 1995
14. West GA, Matsuura T, Levine AD, Klein JS, Fiocchi C: Interleukin-4 in inflammatory bowel disease and mucosal immune reactivity. Gastroenterology 110:1683-1695, 1996
15. Sartor RB: Cytokines in intestinal inflammation: Pathophysiological and clinical considerations. Gastroenterology 106:533-539, 1994
16. Niessner M, Volk BA: Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 101:428-435, 1995
17. Bogdan C, Nathan C: Modulation and macrophage function by transforming growth factor beta, interleukin-4 and interleukin-10: Ann NY Acad Sci 685:713-739, 1993
18. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE: IL-10 inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by human monocytes. J Exp Med 174:1209-1220, 1991
19. Minty A, Chalon P, Derocq J-M, Dumont X, Guillemot J-C, Kaghad M, Labit C, Leplatois P, Liauzun P, Miloux B, Minty C, Casellas P, Loison G, Lupker J, Shire D, Ferrara P, Caput D: Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362:248-250, 1993
20. Kucharzik T, Lügering N, Weigelt H, Adolf M, Domschke W, Stoll R: Immunoregulatory properties of Interleukin-13 in patients with inflammatory bowel disease. Comparison with interleukin-4 and interleukin-10. Clin Exp Immunol 104:483-490, 1996
21. De Waal Malefyt R, Figdor CG, Huijbens R, Mohan Peterson S, Bennett B, Culpepper J, Dang W, Zurawsky G, de Vries JE: Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-γ or IL-10. J Immunol 151:6370-6381, 1993
22. D'Andrea A, Ma X, Aste-Amezaga M, Paganin C, Trinchieri G: Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: Priming for IL-12 and tumor necrosis factor-α production. J Exp Med 181:537-546, 1995
23. Te Velde AA, De Waal Malefyt R, Huijibens RJF, de Vries JE, Figdor CG: IL-10 stimulates monocyte FcγR surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-γ, IL-4, and IL-10. J Immunol 149:4048-4052, 1992
24. Hsu DH, Moore KW, Spits H: Differential effects of IL-4 and IL-10 on IL-2-induced IFN-gamma synthesis and lymphokine-activated killer activity. Int Immunol 4:563-569, 1992
25. Wang P, Wu P, Siegel MI, Egan RW, Billah MM: Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monoeytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanism. J Biol Chem 270:9558-9563, 1995
26. Joyce DA, Gibbons DP, Green P, Steer JH, Feldmann M, Brennan FM: Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur J Immunol 24:2699-2705, 1994
27. Nahioullin R, Sone S, Mizuno K, Yano S, Nishioka Y, Haku T, Ogura T: Interleukin-10 is a potent inhibitor of tumor cytoloxicity by human monocytes and alveolar macrophages. J Leukoc Biol 55:437-442, 1994
28. Rachmilewitz D: Coated mesalazine (5-amino-salicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized trial. Br Med J 198:82-86, 1989
29. Best WR, Becktel JM, Singleton JW, Kern FR: Development of a Crohn's disease activity index: National cooperative Crohn's disease study. Gastroenterology 101:782-785, 1976
30. Feige U, Overwien B, Sorg C: Purification of human blood monocytes by hypotonie density gradient centrifugation in Percoll. J Immunol Methods 54:309-315, 1982
31. Hart PH, Ahern MJ, Jones CA, Jones KL, Smith MD, Finlay-Jones JJ: Synovial fluid macrophages and blood monocytes differ in their responses to IL-4. J Immunol 51:3370-3380, 1993
32. Hart PH, Ahern MJ, Smith MD, Finlay-Jones JJ: Regulatory effects of IL-13 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Clin Exp Immunol 99:331-339, 1995
33. Zurawski G, De Vries JE: Interleukin-13, an interleukin-4-like cytokine that acts on monocytes and B cells, but not on T-cells. Immunol Today 15:19-26, 1994
34. Aversa G, Punnonen J, Cocks BG, de Waal Malefyt R, Vega F, Zurawski SM, Zurawski G, de Vries JE: An interleukin 4 (IL-4) mutant protein inhihits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J Exp Med 178:2213-2208, 1993
35. Zurawski SM, Vega F Jr, Huyghe B, Zurawski G: Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J 12:2663-2670, 1993
36. Young DA, Lowe LD, Clark SC: Comparison of effects of IL-3, granulocyte-macrophage colony-stimulating factor, and macrophage colony-stimulating factor in supporting monocyte differentiation in culture. Analysis of macrophage antibody dependent cellular cytotoxicity. J Immunol 145:607-615, 1990
37. Rutherford MS, Witsell A, Schock LB: Mechanisms generating functionally heterogenous macrophages: Chaos revisited. J Leukocyte Biol 48:43-49, 1993
38. Hart PH, Jones CA, Finlay-Jones JJ: Monocytes cultured in cytokine-defined environments differ from freshly isolated monocytes in their responses to IL-4 and IL-10. J Leukocyte Biol 57:909-918, 1995
39. Del Prete G, De Carli M, Almerigogna F, Grazia Giudizi M, Biagotti R, Romagnani S: Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 150:353-360, 1993
40. Mosmann TR, Coffman RL: Two type of mouse helper T cell clone: Implication for immune regulation. Immunol Today 8:233, 1987